Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 338 of 6351
-
Liver-Targeted therapy plus immunotherapy shows promise for advanced melanoma
Disease control Recruiting nowThis study is being done to see if combining HEPZATO KIT™ with nivolumab and relatlimab (Opdualag™) in patients with metastatic melanoma with liver metastasis is safe, tolerable, and will have a synergistic effect leading to improved clinical outcomes compared to the historic coh…
Phase 1/2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New urine test aims to catch aggressive prostate cancer early
Diagnosis Not yet recruitingThis clinical trial tests how well a urine prostate cancer screening test, My Prostate Score 2 (MPS2), integrated with magnetic resonance imaging (MRI) works for early detection of prostate cancer. MPS2 is an investigational urine-based test designed to help identify the likeliho…
Sponsor: University of Michigan Rogel Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Could chemo after surgery stop pancreatic tumor return?
Disease control Not yet recruitingADJUPANET is an open label, double arm, multicenter, phase 3 trial that aims to investigate the efficacy of systemic chemotherapy in locally resected aggressive pancreatic neuroendocrine tumors. The two arms of patients are the following : i. control arm : active surveillance onl…
Phase 3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
30,000 seniors to wear heart patches in massive Stroke-Prevention study
Diagnosis Not yet recruitingThis prospective, multicenter, single-arm study evaluates the effectiveness of a single-lead patch electrocardiogram (ECG) recorder in screening for atrial fibrillation (AF) among community-dwelling elderly individuals aged ≥60 years in China. Participants will undergo 7 days of …
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Digital sleep therapy aims to stop depression before it starts in young adults
Prevention Not yet recruitingDepression is a leading cause of global disease burden, poor quality of life, disability and suicide, and commonly occurs in adolescence and early adulthood. Insomnia and circadian factors were regarded as potential targets for preventing worsening of depressive symptoms. Additio…
Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Zapping nerves with radiation may ease pancreatic cancer pain
Symptom relief Not yet recruitingPain from advanced pancreatic cancer is often difficult to control. This pain commonly occurs when the cancer affects a network of nerves in the abdomen called the coeliac plexus. Even strong pain medicines, including morphine and related drugs, may not give enough relief. Some p…
Phase 2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
A new program aims to help teens thrive when a parent faces cancer
Symptom relief Not yet recruitinge purpose of this study is to develop and evaluate SHINE (Support and Healing Intervention for Navigating Parental Cancer Experiences), a family-centered program designed to support adolescents whose parent has been diagnosed with cancer. The study has two phases. In the first p…
Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Could a daily probiotic soothe teen anxiety?
Symptom relief Not yet recruitingThe purpose of this study is to evaluate changes in self-reported wellbeing outcomes in adolescents. Bifidobacterium longum, 1714™ has previously been associated with beneficial effects on stress-related outcomes, sleep quality, subjective wellbeing and aspects of cognitive perfo…
Sponsor: Novonesis • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Will leg workouts save muscle while Weight-Loss drugs shed pounds?
Disease control Not yet recruitingTreatment with appetite suppressant drugs, including incretin-based receptor agonists, generally leads to clinically meaningful weight loss and reduced cardiometabolic risk. However, weight loss may include not only loss of adipose tissue but also loss of skeletal muscle mass, wh…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
AI may predict transfusion needs to shield ICU patients from organ failure
Knowledge-focused Not yet recruitingThis multicenter observational study aims to develop and validate an artificial intelligence-based precision transfusion prediction model for critically ill patients. The study will collect clinical characteristics, laboratory parameters, transfusion-related information, physiolo…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a tailored rehab boost recovery after pancreatic surgery?
Symptom relief Not yet recruitingThe REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy …
Sponsor: IRCCS San Raffaele • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Could a daily supplement recharge aging cells?
Prevention Not yet recruitingThis randomized, double-blind, placebo-controlled clinical trial will investigate whether 10 weeks of CoQ10 supplementation can improve biological resilience and functional health in community-dwelling adults aged 65 years or older with signs of reduced biological resilience or p…
Sponsor: University Medical Centre Ljubljana • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Can a Dual-Action antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis study is an open-label, multicenter, dose-escalation and expansion, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advance…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Direct-to-Brain chemo route outsmart resistant lung cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the Thiotepa administration via Ommaya Reservoir works to treat non-small cell lung cancer with leptomeningeal metastases resistant to EGFR TKI. The main questions to answer are: Is Thiotepa administration via Ommaya Reservoir safe …
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can an eczema cream fight a rare skin cancer?
Disease control Not yet recruitingThis study tests whether a cream named delgocitinib (Anzupgo), applied twice daily to the skin, is safe and well tolerated in people with early-stage cutaneous T-cell lymphoma (a rare type of skin cancer called mycosis fungoides). The cream works by blocking proteins called JAK e…
Phase 2 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Digital toolkit aims to empower families in the opioid crisis
Symptom relief Not yet recruitingEvidence suggests that friends and family play an important role in supporting loved ones that are addicted to opioids. However, there are limited unique resources available for this population of friends and family. This study aims to develop a brief digital educational interven…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can a smaller stent tame brain fog after liver shunt surgery?
Disease control Recruiting nowRefractory hepatic encephalopathy (RHE) after transjugular intrahepatic portosystemic shunt (TIPS) is a serious complication that can markedly impair quality of life and worsen prognosis. Standard medical management-including lactulose, rifaximin, nutritional support, and correct…
Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
A free school lunch a day: could it fight malnutrition and boost grades?
Prevention Not yet recruitingThis study will assess the impact of a school meal program on the nutritional status and academic performance of primary school children in Lahore, Pakistan. Children aged 6-11 years from selected government primary schools will participate in the study. Children in the intervent…
Sponsor: University of Veterinary and Animal Sciences, Lahore - Pakistan • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Can a coordinated care team reduce severe side effects in older cancer patients?
Disease control Not yet recruitingThe incidence of cancer among older adults is increasing as a result of longer life expectancy. Therapeutic advances have led oncologists to propose new available treatments for these patients, particularly oral therapies, whether targeted therapies or hormone therapies. However,…
Phase 4 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Exercise, diet, and sleep: a new attack plan against chronic migraine?
Symptom relief Not yet recruitingMigraine is a highly prevalent neurological disorder and one of the leading causes of disability worldwide, substantially affecting quality of life and individuals during their most productive years. Chronic migraine, defined as headache occurring on ≥15 days per month for more t…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC